April 17, 2025 - 15:59

Life sciences recruiting specialist has successfully facilitated the appointment of Luis De Miguel Puig as the new chief data and technology officer at Clinical Partners. The recruitment process was praised for its efficiency and effectiveness, with Clinical Partners' CEO, Barny Guthrie, expressing satisfaction with the outcome. He noted that the firm comprehended the specific needs of the organization, particularly in finding a leader capable of driving automation, self-service initiatives, and a robust data-driven strategy.
Guthrie highlighted the impressive and diverse shortlist provided by the recruiting firm, which was delivered in under 30 days. This swift turnaround demonstrates not only the expertise of the recruiting team but also their understanding of the evolving landscape of healthcare technology. The addition of Puig is expected to enhance Clinical Partners' capabilities in leveraging data and technology to improve clinical outcomes and operational efficiencies, marking a significant step forward for the organization in its mission to innovate within the healthcare sector.
June 7, 2026 - 04:47
Analyst See More Upside Despite Micron Technology’s (MU) 90% Gains in MayDespite Micron Technology already delivering a stunning 90% gain for investors in May 2026, Wall Street analysts are not backing off. Instead, they are raising their price targets, signaling that...
June 6, 2026 - 04:34
AI Takes Center Stage in 2026 Global Tech Leadership StudyTechnology leaders are shifting their focus dramatically, with artificial intelligence becoming the central pillar of their strategic planning. According to the 2026 Global Technology Leadership...
June 5, 2026 - 04:34
Grass Valley’s Ben Dolinky on Offering Teachable Technology to College Students Across the CountryCollegiate sports production programs face a unique challenge. They must deliver polished, broadcast-ready shows for major networks like ESPN, but their primary mission is education. Ben Dolinky, a...
June 4, 2026 - 11:45
Jeremy Grantham: Distinguishing Great Technology From Great InvestmentsFew investors have spent as much time studying market bubbles as Jeremy Grantham. Over the course of his career, the GMO co-founder correctly identified some of the most significant speculative...